Press releases

Today, Sobi™ and Sanofi will present data demonstrating that Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa) can provide perioperative haemostatic control across a wide spectrum of major and minor surgeries in subjects of all ages with severe haemophilia A...

05/10/2019 - 09:05

The Sobi AGM was convened earlier today in Stockholm and voted in favour of the resolutions proposed at the meeting, including:

Adoption of the profit and loss statements and balance sheet and discharge of liability

The AGM adopted the income statements and the balance...

05/09/2019 - 17:30

Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Amy Pott as the new Head of Sobi North America. She takes over effective today, replacing Rami Levin who is leaving Sobi.

“Sobi North America is entering a new phase in line with Sobi’s growth strategy, with the...

04/30/2019 - 13:00

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the first quarter 2019. Total revenues were SEK 3,265 M (1,964), with 66 per cent revenue growth in the quarter compared with Q1 2018 (54 per cent at constant exchange rates (CER)). EBITA1...

04/25/2019 - 08:00

Swedish Orphan Biovitrum AB (publ) (Sobi™) has released the company’s 2018 Annual and Sustainability Report. The integrated report summarises our business and strategy, financial performance and work on sustainability.

“2018 was a year of transformation for Sobi,” says...

04/18/2019 - 10:00

Press contacts

Subscribe to our press releases and financial reports